Cell & Gene Therapy Cold Chain Logistics Market - Industry Size, Share, Trend and Forecast 2027 | TechSci Research

1
2017 2027
Global Cell Gene Therapy Cold Chain Logistics
Market
FORECAST AND OPPORTUNITIES
www.techsciresearch.com
MARKET INTELLIGENCE . CONSULTING
2

• Table of Contents

S. No. Contents Contents Contents
1. Service Overview Service Overview Service Overview
2. Research Methodology Research Methodology Research Methodology
3. Executive Summary Executive Summary Executive Summary
4. Voice of Customer Voice of Customer Voice of Customer
4.1. Considerations for Cold Storage in Cell Gene Therapy Logistics Considerations for Cold Storage in Cell Gene Therapy Logistics
4.2. Commonly Used Cryopreservation Techniques Commonly Used Cryopreservation Techniques
4.3. Demand, By Component Demand, By Component
4.4. Demand, By Services Offered Demand, By Services Offered
4.5. Brand Awareness Brand Awareness
5. Impact of COVID-19 on Global Cell Gene Therapy Cold Chain Logistics Market Impact of COVID-19 on Global Cell Gene Therapy Cold Chain Logistics Market Impact of COVID-19 on Global Cell Gene Therapy Cold Chain Logistics Market
6. Global Cell Gene Therapy Market Overview Global Cell Gene Therapy Market Overview Global Cell Gene Therapy Market Overview
7. Global Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Global Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Global Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
7.1. Market Size Forecast Market Size Forecast
7.1.1. By Value
7.2. Market Share Forecast Market Share Forecast
7.2.1. By Component (Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Cold Chain Management Systems, Shipment and Storage Medium, Cryogenic Packout Kits Others Shipment Containers, Reusable Boxes, etc.)
7.2.2. By Services Offered (Transportation, Storage, Packaging)
7.2.3. By Mode of Transportation (Air, Ground, Water)
7.2.4. By Holding Temperature Range (Cryogenic, Refrigerated, Ambient, Others Deep Freezers, Dry Ice, etc.)
7.2.5. By End User (Pharmaceutical Biotechnology Companies, Academic Research Institutes, Others)
7.2.6. By Region
7.2.7. By Company (2021)
7.3. Market Map Market Map
Air Coolers
2
3

• Table of Contents

S. No. Contents Contents Contents Contents Contents
8. North America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F North America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F North America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F North America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F North America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
8.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
8.1.1. By Value By Value By Value
8.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
8.2.1. By Component By Component By Component
8.2.2. By Services Offered By Services Offered By Services Offered
8.2.3. By Mode of Transportation By Mode of Transportation By Mode of Transportation
8.2.4. By Holding Temperature Range By Holding Temperature Range By Holding Temperature Range
8.2.5. By End User By End User By End User
8.2.6. By Country By Country By Country
8.3. North America Country Analysis North America Country Analysis North America Country Analysis North America Country Analysis
8.3.1. United States Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017- 2027F United States Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017- 2027F United States Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017- 2027F
8.3.1.1. Market Size Forecast Market Size Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share Forecast Market Share Forecast
8.3.1.2.1. By Component
8.3.1.2.2. By Services Offered
8.3.1.2.3. By Mode of Transportation
8.3.1.2.4. By Holding Temperature Range
8.3.1.2.5. By End User
8.3.2. Canada Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Canada Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Canada Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
Air Coolers
3
4

• Table of Contents

S. No. Contents Contents Contents Contents Contents
8.3.2.1. Market Size Forecast Market Size Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share Forecast Market Share Forecast
8.3.2.2.1. By Component
8.3.2.2.2. By Services Offered
8.3.2.2.3. By Mode of Transportation
8.3.2.2.4. By Holding Temperature Range
8.3.2.2.5. By End User
8.3.3. Mexico Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Mexico Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Mexico Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
8.3.3.1. Market Size Forecast Market Size Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share Forecast Market Share Forecast
8.3.3.2.1. By Component
8.3.3.2.2. By Services Offered
8.3.3.2.3. By Mode of Transportation
8.3.3.2.4. By Holding Temperature Range
8.3.3.2.5. By End User
9. Europe Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Europe Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Europe Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Europe Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Europe Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
9.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
9.1.1. By Value By Value By Value
9.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
9.2.1. By Component By Component By Component
Air Coolers
4
5

• Table of Contents

S. No. Contents Contents Contents Contents Contents
9.2.2. By Services Offered By Services Offered By Services Offered
9.2.3. By Mode of Transportation By Mode of Transportation By Mode of Transportation
9.2.4. By Holding Temperature Range By Holding Temperature Range By Holding Temperature Range
9.2.5. By End User By End User By End User
9.2.6. By Country By Country By Country
9.3. Europe Country Analysis Europe Country Analysis Europe Country Analysis Europe Country Analysis
9.3.1. Germany Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Germany Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Germany Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
9.3.1.1. Market Size Forecast Market Size Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share Forecast Market Share Forecast
9.3.1.2.1. By Component
9.3.1.2.2. By Services Offered
9.3.1.2.3. By Mode of Transportation
9.3.1.2.4. By Holding Temperature Range
9.3.1.2.5. By End User
9.3.2. France Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F France Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F France Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
9.3.2.1. Market Size Forecast Market Size Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share Forecast Market Share Forecast
9.3.2.2.1. By Component
9.3.2.2.2. By Services Offered
9.3.2.2.3. By Mode of Transportation
Air Coolers
5
6

• Table of Contents

S. No. Contents Contents Contents Contents Contents
9.3.2.2.4. By Holding Temperature Range
9.3.2.2.5. By End User
9.3.3. United Kingdom Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F United Kingdom Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F United Kingdom Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
9.3.3.1. Market Size Forecast Market Size Forecast Market Size Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share Forecast Market Share Forecast Market Share Forecast
9.3.3.2.1. By Component
9.3.3.2.2. By Services Offered
9.3.3.2.3. By Mode of Transportation
9.3.3.2.4. By Holding Temperature Range
9.3.3.2.5. By End User
9.3.4. Spain Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Spain Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Spain Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
9.3.4.1. Market Size Forecast Market Size Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share Forecast Market Share Forecast
9.3.4.2.1. By Component
9.3.4.2.2. By Services Offered
9.3.4.2.3. By Mode of Transportation
9.3.4.2.4. By Holding Temperature Range
9.3.4.2.5. By End User
9.3.5. Italy Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Italy Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Italy Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
Air Coolers
6
7

• Table of Contents

S. No. Contents Contents Contents Contents Contents
9.3.5.1. Market Size Forecast Market Size Forecast
9.3.5.1.1 By Value
9.3.5.2. Market Share Forecast Market Share Forecast
9.3.5.2.1. By Component
9.3.5.2.2. By Services Offered
9.3.5.2.3. By Mode of Transportation
9.3.5.2.4. By Holding Temperature Range
9.3.5.2.5. By End User
10. Asia Pacific Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Asia Pacific Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Asia Pacific Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Asia Pacific Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Asia Pacific Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
10.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
10.1.1. By Value By Value By Value
10.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
10.2.1. By Component By Component By Component
10.2.2. By Services Offered By Services Offered By Services Offered
10.2.3. By Mode of Transportation By Mode of Transportation By Mode of Transportation
10.2.4. By Holding Temperature Range By Holding Temperature Range By Holding Temperature Range
10.2.5. By End User By End User By End User
10.2.6. By Country By Country By Country
10.3. Asia Pacific Country Analysis Asia Pacific Country Analysis Asia Pacific Country Analysis Asia Pacific Country Analysis
10.3.1. China Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F China Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F China Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
10.3.1.1. Market Size Forecast Market Size Forecast
10.3.1.1.1. By Value
Air Coolers
7
8

• Table of Contents

S. No. Contents Contents Contents Contents Contents
10.3.1.2. Market Share Forecast Market Share Forecast
10.3.1.2.1. By Component
10.3.1.2.2. By Services Offered
10.3.1.2.3. By Mode of Transportation
10.3.1.2.4. By Holding Temperature Range
10.3.1.2.5. By End User
10.3.2. Japan Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Japan Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Japan Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
10.3.2.1. Market Size Forecast Market Size Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share Forecast Market Share Forecast
10.3.2.2.1. By Component
10.3.2.2.2. By Services Offered
10.3.2.2.3. By Mode of Transportation
10.3.2.2.4. By Holding Temperature Range
10.3.2.2.5. By End User
10.3.3. South Korea Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F South Korea Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F South Korea Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
10.3.3.1. Market Size Forecast Market Size Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share Forecast Market Share Forecast
10.3.3.2.1. By Component
10.3.3.2.2. By Services Offered
10.3.3.2.3. By Mode of Transportation
10.3.3.2.4. By Holding Temperature Range
10.3.3.2.5. By End User
Air Coolers
8
9

• Table of Contents

S. No. Contents Contents Contents Contents Contents
10.3.4. Australia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Australia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Australia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
10.3.4.1. Market Size Forecast Market Size Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share Forecast Market Share Forecast
10.3.4.2.1. By Component
10.3.4.2.2. By Services Offered
10.3.4.2.3. By Mode of Transportation
10.3.4.2.4. By Holding Temperature Range
10.3.4.2.5. By End User
10.3.5. India Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F India Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F India Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
10.3.5.1. Market Size Forecast Market Size Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share Forecast Market Share Forecast
10.3.5.2.1. By Component
10.3.5.2.2. By Services Offered
10.3.5.2.3. By Mode of Transportation
10.3.5.2.4. By Holding Temperature Range
10.3.5.2.5. By End User
Air Coolers
9
10

• Table of Contents

S. No. Contents Contents Contents Contents Contents
11. South America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F South America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F South America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F South America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F South America Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
11.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
11.1.1. By Value By Value By Value
11.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
11.2.1. By Component By Component By Component
11.2.2. By Services Offered By Services Offered By Services Offered
11.2.3. By Mode of Transportation By Mode of Transportation By Mode of Transportation
11.2.4. By Holding Temperature Range By Holding Temperature Range By Holding Temperature Range
11.2.5. By End User By End User By End User
11.2.6. By Country By Country By Country
11.3. South America Country Analysis South America Country Analysis South America Country Analysis South America Country Analysis
11.3.1. Brazil Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Brazil Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Brazil Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
11.3.1.1. Market Size Forecast Market Size Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share Forecast Market Share Forecast
11.3.1.2.1. By Component
11.3.1.2.2. By Services Offered
11.3.1.2.3. By Mode of Transportation
11.3.1.2.4. By Holding Temperature Range
11.3.1.2.5. By End User
11.3.2. Argentina Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Argentina Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Argentina Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
Air Coolers
10
11

• Table of Contents

S. No. Contents Contents Contents Contents Contents
11.3.2.1. Market Size Forecast Market Size Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share Forecast Market Share Forecast
11.3.2.2.1. By Component
11.3.2.2.2. By Services Offered
11.3.2.2.3. By Mode of Transportation
11.3.2.2.4. By Holding Temperature Range
11.3.2.2.5. By End User
11.3.3. Colombia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Colombia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Colombia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
11.3.3.1. Market Size Forecast Market Size Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share Forecast Market Share Forecast
11.3.3.2.1. By Component
11.3.3.2.2. By Services Offered
11.3.3.2.3. By Mode of Transportation
11.3.3.2.4. By Holding Temperature Range
11.3.3.2.5. By End User
12. Middle East Africa Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Middle East Africa Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Middle East Africa Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Middle East Africa Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Middle East Africa Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
12.1. Market Size Forecast Market Size Forecast Market Size Forecast Market Size Forecast
12.1.1. By Value By Value By Value
12.2. Market Share Forecast Market Share Forecast Market Share Forecast Market Share Forecast
12.2.1. By Component By Component By Component
Air Coolers
11
12

• Table of Contents

S. No. Contents Contents Contents Contents Contents
12.2.2. By Services Offered By Services Offered By Services Offered
12.2.3. By Mode of Transportation By Mode of Transportation By Mode of Transportation
12.2.4. By Holding Temperature Range By Holding Temperature Range By Holding Temperature Range
12.2.5. By End User By End User By End User
12.2.6. By Country By Country By Country
12.3. Middle East Africa Country Analysis Middle East Africa Country Analysis Middle East Africa Country Analysis Middle East Africa Country Analysis
12.3.1. Israel Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Israel Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Israel Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
12.3.1.1. Market Size Forecast Market Size Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share Forecast Market Share Forecast
12.3.1.2.1. By Component
12.3.1.2.2. By Services Offered
12.3.1.2.3. By Mode of Transportation
12.3.1.2.4. By Holding Temperature Range
12.3.1.2.5. By End User
12.3.2. South Africa Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F South Africa Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F South Africa Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
12.3.2.1. Market Size Forecast Market Size Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share Forecast Market Share Forecast
12.3.2.2.1. By Component
12.3.2.2.2. By Services Offered
12.3.2.2.3. By Mode of Transportation
Air Coolers
12
13

• Table of Contents

S. No. Contents Contents Contents Contents Contents
12.3.2.2.1. By Holding Temperature Range
12.3.2.2.2. By End User
12.3.3. Saudi Arabia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Saudi Arabia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F Saudi Arabia Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
12.3.3.1. Market Size Forecast Market Size Forecast Market Size Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share Forecast Market Share Forecast Market Share Forecast
12.3.3.2.1. By Component
12.3.3.2.2. By Services Offered
12.3.3.2.3. By Mode of Transportation
12.3.3.2.4. By Holding Temperature Range
12.3.3.2.5. By End User
12.3.4. UAE Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F UAE Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F UAE Cell Gene Therapy Cold Chain Logistics Market Outlook, 2017-2027F
12.3.4.1. Market Size Forecast Market Size Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share Forecast Market Share Forecast
12.3.4.2.1. By Component
12.3.4.2.2. By Services Offered
12.3.4.2.3. By Mode of Transportation
12.3.4.2.4. By Holding Temperature Range
12.3.4.2.5. By End User
Air Coolers
13
14

• Table of Contents

S. No. Contents Contents Contents
13. Market Dynamics Market Dynamics Market Dynamics
13.1. Drivers Drivers
13.2. Challenges Challenges
14. Market Trends and Developments Market Trends and Developments Market Trends and Developments
15. Competitive Landscape Competitive Landscape Competitive Landscape
15.1. Company Profiles Company Profiles
15.1.1. AmerisourceBergen Corporation (World Courier)
15.1.2. United Parcel Service (Marken)
15.1.3. Catalent, Inc.
15.1.4. BioLife Solutions, Inc.
15.1.5. Cryoport, Inc.
15.1.6. Atelerix Ltd.
15.1.7. Biostor Ltd.
15.1.8. Thermo Fisher Scientific Inc.
15.1.9. Life Science Group Ltd (LSG)
15.1.10. Yourway Biopharma Services Company
15.1.11. Bertelsmann SE Co. KGaA (Arvato Supply Chain Solutions)
15.1.12. Be The Match Therapeutics
16. Strategic Recommendations Strategic Recommendations Strategic Recommendations
17. About Us Disclaimer About Us Disclaimer About Us Disclaimer
Air Coolers
14
15
Service Overview
16

• Scope of Report
• Service of Interest (SOI) Cell Gene Therapy
  Cold Chain Logistics

Cell Gene Therapies are an evolving field of
biomedical research and treatment. These
therapies are designed to prevent, treat, and
cure diseases, especially genetic disorders and
acquired diseases. Cold Chain Logistics in cell
gene therapy refers to the sequence of
transportation events required to maintain the
temperature within approved specifications from
the manufacturers of the cell gene therapy
products through to the packaged product at the
end user.
Market Segmentation

By End User
By Component
By Services Offered

• Transportation
• Storage
• Packaging

• Cryogenic Shippers
• Cryogenic Storage Freezers
• Ultra Low Freezers
• Cold Chain Management Systems
• Shipment and Storage Medium
• Cryogenic Packout Kits
• Others

• Pharmaceutical Biotechnology Companies
• Academic Research Institutes
• Others

By Mode of Transportation

• Air
• Ground
• Water

By Region

• North America
• Europe
• Asia Pacific
• South America
• Middle East Africa

By Holding Temperature Range

• Cryogenic
• Refrigerated
• Ambient
• Others

16
17
Research Methodology
18

• Research Methodology

Market Profiling
Data Analysis
Data Collection
Data Validation
Developing list of respondents
Formulating Questionnaire
In-depth secondary research was conducted to
determine the overall market size, segmental
market size and top players in the global cell
gene therapy cold chain logistics market.
The data was scrutinized using MS-Excel,
statistical tools and internal proprietary
database to obtain qualitative and quantitative
insights about the global cell gene therapy
cold chain logistics market.
Data obtained as a result of primary and
secondary research was validated through rigorous
triangulation.
TechSci conducted interviews with industry
experts and industry players for data collection
and verification.
In order to conduct industry experts interviews,
TechSci formulated a detailed discussion guide.
List of industry players and industry specialists
was developed.
Primary Research
Desk Research
Company Analysis

• Recent Developments
• Market Changing Aspects/Dynamics
• Government Policies
• Final Conclusion

• Market Participants
• Key Strengths

• Identifying Key Opinion Leaders
• Questionnaire Design
• In-depth Interviews

18
19

• Research Methodology

• Baseline Methodology
• Our dedicated team of industry experts has
  monitored and analyzed various aspects of the
  global cell gene therapy cold chain logistics
  market. The team has analyzed the outlook of
  various segments of this market, while
  considering the major influencing factors such as
  growing prevalence of different genetic disorders
  and acquired diseases, growing popularity of
  precision medicine, among others. The study
  includes market forecasting, which would enable
  our clients to take better decisions while
  planning their strategy to achieve sustainability
  in the global cell gene therapy cold chain
  logistics market.
• Methodology Followed for Calculation of Market
  Size
• Market Size by Value Market size, in terms of
  value, for the year 2021 was calculated based on
  information collected through exhaustive
  secondary research and primary surveys, with
  various key opinion leaders/stakeholders, such as
  cell gene therapy cold chain logistics
  companies, channel partners, end users, industry
  experts, and other industry participants.
• The team interviewed more than 15 cell gene
  therapy cold chain logistics companies, 100 end
  users and 10 industry experts and other value
  chain stakeholders in the global cell gene
  therapy cold chain logistics market to obtain the
  overall market size from 2017 to 2021, which was
  validated by the Delphi technique. Taking
  standard deviation into consideration, the market
  size was averaged out, to arrive at the market
  size data during 2017-2021.
• Respondents were asked about the current and
  future market growth rates, market shares by
  component, by services offered, by mode of
  transportation, by holding temperature range, by
  end user, by region and by company. Removing the
  outlier responses, the geometric mean of growth
  estimates and category wise revenue shares
  generated across various segments were
  considered,

19
20

• Research Methodology

• to arrive at the final revenue shares. Revenue
  shares generated across various segments were
  further triangulated based on the response
  received from other stakeholders.
• Methodology Followed for Calculation of Market
  Shares
• Market shares by component, by services offered,
  by mode of transportation, by holding temperature
  range, by end user, by region and by company were
  calculated based on the responses received
  through primary surveys with industry experts, in
  which the respondents were asked about the market
  shares or revenue generated from various segments
  of the global cell gene therapy cold chain
  logistics market. The final shares were
  calculated by taking the geometric mean of the
  responses gathered from key opinion leaders after
  eliminating the outliers.
• Methodology Followed for Forecasting
• TechSci Research performed periodical checks on
  data collected through the surveys with logic
  checks and analyzed the survey results in
  SPSS/Tableau Software. Data triangulation
  techniques were applied to fill the gaps and to
  present a more meaningful picture of the market.
  To forecast the global cell gene therapy cold
  chain logistics market, TechSci Research used
  various forecast techniques such as
• Moving Average
• Time Series Analysis
• Regression Analysis
• Econometric and Judgmental Analysis

• Note
• Sum of some shares may not be 100 due to round
  off till two decimal places.
• The actual market data for 2021 is for nine
  months till Sep 2021. For rest of three months
  (Oct 2021- Dec 2021), the data is estimated.

20
21

• Research Methodology

TechSci Research used its own forecast tool,
which is based on the growth of various allied
industries in respective regions. TechSci
Research also used the impact analysis during
short, medium and long term period to estimate
the demand and to reach accurate market numbers.
The currency used in the report is the United
States Dollar (with the market size indicated in
USD million).
Partial List of Companies Interviewed Key Secondary Sources
AmerisourceBergen Corporation (World Courier) United Parcel Service (Marken) Catalent, Inc. BioLife Solutions, Inc. Cryoport, Inc. Atelerix Ltd. Biostor Ireland Ltd Thermo Fischer Scientific, Inc. Life Science Group Ltd (LSG) Yourway Biopharma Services Company Bertelsmann SE Co. KGaA (Arvato Supply Chain Solutions) Be The Match Biotherapies World Bank TechSci Research Proprietary Database Knowledge Repository Company Annual Reports Industry Magazines Industry Reports Food and Drug Administration (FDA) Credible Paid Databases International Diabetes Foundation Centers for Disease Control and Prevention World Health Organization (WHO) Global Cancer Observatory (Globocan)
21
22

• Industry Brief

According to TechSci Research report, Cell
Gene Therapy Cold Chain Logistics Market - Global
Industry Size, Share, Trends, Opportunity, and
Forecast, 2017-2027, the global cell gene
therapy cold chain logistics market stood at USD
1316.93 Million in 2021 and is expected to grow
at a steady CAGR of 14.29 during the forecast
period on account of rising demand for
personalized treatment across the globe. The
global cell gene therapy cold chain logistics
market is expected to grow at a robust rate
during the forecast period on account of
increasing RD activities related to production
of cell gene therapy products by major
companies around the globe. Additionally, many
players who are operating in the healthcare
industry or cell gene therapy development
industry have started entering into the cell
gene therapy cold chain logistics industry as
well. These companies are either developing
different products or solutions required for
storage and preserving cell gene therapy
products in cold chain or are opening their own
cold chain solutions or the bigger players are
acquiring the existing small players or entering
into partnerships agreements, thereby creating
opportunities for overall market growth. For
instance, Catalent, Inc, in June 2021, added
cryogenic capabilities to its 200,000 square foot
facility in Philadelphia. Additionally due to
personalized nature of some products, the task at
hand is to comprehend each component of this
supply chain, as well as their specific
requirements. Transportation of gene treatments
in situations other than those required for
specific purposes can stifle industry
expansion. The global cell gene therapy cold
chain logistics market is segmented based on
component, services offered, mode of
transportation, holding temperature range, end
user, and regional distribution.Based on
component, the market can be split into cryogenic
shippers, cryogenic storage freezers, ultra-low
freezers, cold chain management systems,
shipment, and storage medium, cryogenic packout
kits, others. The cryogenic shippers are expected
to dominate the market during forecast period.
Based on services offered, the market can be
divided into transportation, storage, packaging.
Transportation segment dominated the market as
the biopharma logistics companies offer various
services, and transportation is one of the
majorly offered key services being taken by the
pharmaceutical companies. As the
biopharmaceutical sector is increasing its
dominance globally, logistics companies tend to
add other value-added services as well, which
mainly comprises storage and packaging. Packaging
and storage require specific cold chain
maintenance systems as well as refrigerated and
cryogenic shippers.Hence, companies are moving
forward to add other services on their portal
along with transportation to emerge in the
competitive world. In terms of mode of
transportation, the market is divided into air,
ground, water. Air transportation is one of the
most preferred modes of supply chain logistics
market in the cell and gene therapy segment. It
offers a quick, more reliable, and equipped
source to transfer the cell and gene therapy
samples in short deadlines. Ground or road
transport is also growing substantially to meet
the increasing consumer needs and requirements.
For inter- and intra-state shipments, road
transport is preferred as it is a cost-effective
and prominent mode of delivery. In terms of
holding temperature range, the market can be
categorized into cryogenic, refrigerated,
ambient, others Cryogenic shippers provide a safe
and convenient method of shipping cell and gene
therapy products. These shippers are designed
with anterior walls to hold a cooling medium and
the product is stored in an interior chamber.
They usually come in a variety of sizes, with
various options for shipment of approximately
1000 vials or less, depending upon the size of
the container. These shippers comply with
numerous flight regulations, and they could be
handled by major flight carriers. Ultra-low
freezers are mechanical freezers capable of
maintaining temperature approximately -150
degrees Celsius. The major function of these
components is to store and deliver the cell and
gene therapy products while maintaining their
viability. Based on end user, the market can be
segmented into pharmaceutical biotechnology
companies, academic research institutes,
others. Pharmaceutical and biotechnology
companies is the leading segment amongst all due
to capital investments, government support as
well as regulations. These pharmaceutical and
biotechnology companies aim to develop therapies
and sell them across the world. These
biotechnology firms have the capacity to deliver
quality care and medical requirements as per the
latest innovation and technology developed by
them. Key market players in the cell gene
therapy cold chain logistics market include
 AmerisourceBergen Corporation (World Courier),
United Parcel Service (Marken), Catalent, Inc.,
BioLife Solutions, Inc., Cryoport, Inc., Atelerix
Ltd., Biostor Ireland Ltd, Thermo Fischer
Scientific, Inc., Life Science Group Ltd (LSG),
Yourway Biopharma Services Company, Bertelsmann
SE Co. KGaA (Arvato Supply Chain Solutions), Be
The Match Biotherapies Asia Pacific is expected
to be the fastest growing region in global cell
gene therapy cold chain logistics market during
forecast years since China is the major center of
research for the research and development of cell
and gene therapy, hence witnesses a great demand
for the cell and gene therapy cold chain
logistics market.  Additionally, China ranks
second after the United States in the global cell
therapy manufacturing market. Between 2017 and
2019, the Chinese government granted thousands of
patents related to cell and gene therapy, and
around 1000 clinical trials were either conducted
or were underway during this period.
Additionally, the expansion of Showa Denkos
Minaris in Japan adjacent to its existing site in
Yokohama will further open up new opportunities
for the growth of cell therapy manufacturing in
the country and the Asia Pacific region. Minaris
will be investing about USD23.8 million in
building this 43,056-square-feet new facility.
there will be additional demand of Cell gene
therapy which can witness the phenomenal demand
for these cell gene therapy cold chain
logistics in the coming days. said Mr. Karan
Chechi, Research Director with TechSci Research,
a research based Global management consulting
firm.
22
23

• Sample Data - Snapshot

Global Cell Gene Therapy Cold Chain Logistics
Market Size, By Value (USD Million), 2017-2027F
CAGR 2017-2021 By Value xx
CAGR 2022E-2027F By Value xx
Europe Cell Gene Therapy Cold Chain Logistics
Market Share, By Component, By Value, 2017-2027F
United Kingdom Cell Gene Therapy Cold Chain
Logistics Market Share, By Services Offered, By
Value, 2017-2027F
23
24

• Report Ordering

• Report Name Global Cell Gene Therapy
  Cold Chain Logistics Market
• FORECAST AND OPPORTUNITIES
• 2017 2027

License Type Price
Single User License 4900
Multi-User License 5900
Custom Research License 8900
To View Sample OR Purchase Report  
24
25
About Us Disclaimer
TechSci Research is a global market research and
consulting company with offices in the US, UK and
India. TechSci Research provides market research
reports in number of areas to organizations. The
company uses innovative business models that
focus on improving productivity, while ensuring
creation of high-quality reports. The proprietary
forecasting models use various analyses of both
industry-specific and macroeconomic variables on
a state-by-state basis to produce a unique
bottom-up model of a country, regional and
global industry prospects. Combined with the
detailed analysis of company activity and
industry trends, the result is a uniquely rich
evaluation of the opportunities available in the
market.
Related Reports

• Global Clinical Trials Market, By Type
  (Pharmaceutical Trials Vs Medical Device Trials),
  By Phase (Phase I, Phase II, Phase III, Phase
  IV), By Study Design (Interventional,
  Observational, Expanded Access), By Indication
  (Autoimmune/Inflammation, Oncology, CNS,
  Diabetes, Cardiovascular, Others), By End User
  (Clinical Research Organizations, Pharmaceutical
  and Biotechnological Companies, Clinical Testing
  Laboratories, Others), By Company, By Region,
  Forecast Opportunities, 2026
• Global Blockchain In Genomics Market, By Type
  (Public, Federated, Private), By Application
  (Clinical Trials, IP Management, Drug Discovery,
  Data storage and security, Others), By Models
  (Token-economy, Service, Development Platforms,
  Blockchain based software products), By Targets
  (B2B, B2C, C2C), By End User (Pharmaceutical
  companies, Research institutes), By Region,
  Forecast Opportunities, 2025

TechSci Research North America 708 Third
Avenue, Manhattan, New York, United States Tel
1- 646- 360- 1656 Email sales_at_techsciresearch.co
m www.techsciresearch.com
TechSci Research Europe 54, Old brook,
Bretton, Peterborough, United Kingdom Email
sales_at_techsciresearch.com www.techsciresearch.com
TechSci Research Asia-Pacific B 44, Sector
57, Noida, National Capital Region, U.P. -
India Tel [phone] Email
sales_at_techsciresearch.com www.techsciresearch.com
Disclaimer
The contents of this report are based on
information generally available to the public
from sources believed to be reliable. No
representation is made that it is timely,
accurate or complete. TechSci Research has taken
due care and caution in compilation of data as
this has been obtained from various sources
including which it considers reliable and first
hand. However, TechSci Research does not
guarantee the accuracy, adequacy or completeness
of any information and it is not responsible for
any errors or omissions or for the results
obtained from the use of such information and
especially states that it has no financial
liability whatsoever to the subscribers / users
of this report. The information herein, together
with all estimates and forecasts, can change
without notice. All the figures provided in this
document are indicative of relative market size
and are strictly for clients internal
consumption. Usage of the same for purpose other
than internal will require prior approval of
TechSci Research.